International Assets Investment Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

International Assets Investment Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-127	Closed	-$3.06K	–	1249
2023 Q1	$3.06K	Buy	+127	New	+$1.59K	﹤0.01%	960
2021 Q2	–	Sell	-546	Closed	-$7K	–	2083
2021 Q1	$7K	Buy	546 +346	+173%	+$4.87K	﹤0.01%	1707
2020 Q4	$3K	Buy	+200	New	+$3K	﹤0.01%	1851

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

International Assets Investment Management's PRVB Position: Q2 2023 in Review

International Assets Investment Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 127 shares — an estimated $3.06K sold.

International Assets Investment Management first reported a position in PRVB in Q4 2020 and held it in 3 quarters. The position peaked at $7K in Q1 2021. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

International Assets Investment Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
International Assets Investment Management sold 127 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $3.06K.
International Assets Investment Management first reported a position in Provention Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
International Assets Investment Management's Provention Bio, Inc. Common Stock position peaked at $7K in Q1 2021.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on International Assets Investment Management's 13F filing for Q2 2023, filed 20 Jul 2023.